Shandong Buchang Pharmaceuticals Co Ltd (603858) — Tangible Net Worth Ratio
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Tangible Net Worth Ratio of 73.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥2.63 Billion) from net assets (CN¥10.07 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is Shandong Buchang Pharmaceuticals Co Ltd's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Buchang Pharmaceuticals Co Ltd Tangible Net Worth Ratio (2011–2024)
This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 73.9%, reflecting net assets of CN¥10.07 Billion with intangible assets of CN¥2.63 Billion CNY. Also explore Shandong Buchang Pharmaceuticals Co Ltd (603858) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 603858 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.7% | CN¥9.81 Billion | CN¥2.49 Billion | CN¥19.33 Billion | ▼ -4.9 pp |
| 2023 | 79.6% | CN¥11.38 Billion | CN¥2.33 Billion | CN¥20.89 Billion | ▼ -2.6 pp |
| 2022 | 82.2% | CN¥12.28 Billion | CN¥2.19 Billion | CN¥21.95 Billion | ▼ -3.0 pp |
| 2021 | 85.2% | CN¥14.45 Billion | CN¥2.14 Billion | CN¥23.99 Billion | ▲ +0.5 pp |
| 2020 | 84.7% | CN¥13.81 Billion | CN¥2.11 Billion | CN¥22.89 Billion | ▼ -0.9 pp |
| 2019 | 85.6% | CN¥13.79 Billion | CN¥1.98 Billion | CN¥21.19 Billion | ▲ +0.3 pp |
| 2018 | 85.3% | CN¥13.86 Billion | CN¥2.04 Billion | CN¥20.03 Billion | ▲ +0.6 pp |
| 2017 | 84.7% | CN¥13.22 Billion | CN¥2.02 Billion | CN¥19.20 Billion | ▼ -0.2 pp |
| 2016 | 84.9% | CN¥12.71 Billion | CN¥1.92 Billion | CN¥18.67 Billion | ▲ +11.4 pp |
| 2015 | 73.5% | CN¥7.26 Billion | CN¥1.92 Billion | CN¥15.76 Billion | ▼ -11.2 pp |
| 2014 | 84.7% | CN¥4.45 Billion | CN¥680.91 Million | CN¥9.10 Billion | ▼ -2.0 pp |
| 2013 | 86.7% | CN¥4.28 Billion | CN¥569.03 Million | CN¥6.94 Billion | ▼ -4.7 pp |
| 2012 | 91.4% | CN¥4.02 Billion | CN¥346.96 Million | CN¥5.67 Billion | ▲ +0.1 pp |
| 2011 | 91.3% | CN¥2.80 Billion | CN¥244.55 Million | CN¥4.44 Billion | — |